GlassScriptPhysician profile
Amber Peterson
NPI 1518582923
$1,284.98
in general payments reported to CMS, 2019-2025
16 companies · $27.65 in 2025
The $27.65 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.79 · 2022: $138 · 2023: $628 · 2024: $411 · 2025: $27.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $984 · Education: $81.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $984.04 |
| Education | $81.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Taiho Oncology, INC. | $373.67 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $161.78 | 2023-2024 | Keytruda, Lynparza |
| Foundation Medicine, INC. | $128.20 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $124.87 | 2023 | Tagrisso |
| Astellas Pharma US INC | $104.58 | 2023 | Xospata |
| Pfizer INC. | $88.19 | 2023-2024 | |
| Stryker Corporation | $44.78 | 2021 | |
| Daiichi Sankyo INC. | $43.73 | 2022-2023 | Injectafer |
| Amgen INC. | $42.23 | 2022-2023 | Lumakras |
| Intersect Ent, INC. | $36.01 | 2021 | |
| Beigene USA, INC. | $28.32 | 2023 | Brukinsa |
| Novartis Pharmaceuticals Corporation | $27.18 | 2023 | |
| Genzyme Corporation | $24.25 | 2022 | |
| Celgene Corporation | $23.71 | 2023 | Reblozyl |
| Bio Products Laboratory USA, INC. | $18.48 | 2023 | Coagadex, Gammaplex |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $15.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.